Zeiss announced the acquisition of U.S.-based Xradia, Inc.
Zeiss announced that the acquisition of U.S.-based Xradia, Inc. has been completed and Xradia is now operating under the name of Carl Zeiss X-ray Microscopy, Inc. The acquisition further strengthens the position of the ZEISS Microscopy business group, a manufacturer of light, electron, and X-ray microscopes, with solutions for research and routine inspection in materials and life sciences application fields, the company reports in a press statement.
Zeiss says reports the company will leverage its sales force to make the X-ray technology more accessible in a broader range of applications and workflows. Customers will also benefit from direct service capabilities at multiple locations globally.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.